Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan

Summary

To evaluate the efficacy and safety of amlodipine besylate and candesartan cilexetil administered in a fixed-dose combination tablet versus co-administered as their separate formulations in patients with essential hypertension who have shown inadequate response on monotherapy of amlodipine or candesartan cilexetil or who are with blood pressure adequately controlled by co-administration of amlodipine besylate and candesartan cilexetil single agents

Timeline

Start

2017-04-17

Primary completion

2019-04-30

Completion

2019-05-31

Drugs

Indications